Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 01, 2026 09:00 ET | Source: Muscular Dystrophy Association

A Decade of Strength: Muscular Dystrophy Association and Burn Boot Camp Team Up for 10th Annual ‘Be Their Muscle’ Campaign

CHARLOTTE, N.C., April 01, 2026 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) is proud to celebrate a decade of partnership with Burn Boot Camp, a leading boutique fitness franchise,...
March 30, 2026 08:34 ET | Source: Muscular Dystrophy Association

FDA Approves High Dose Regimen of SPINRAZA® for Spinal Muscular Atrophy, Reflecting Progress Made Possible Through Decades of MDA Supported Research

New York, March 30, 2026 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) celebrates today’s announcement that the U.S. Food and Drug Administration (FDA) has approved a High Dose...
March 12, 2026 07:50 ET | Source: Muscular Dystrophy Association

The 2026 MDA Clinical & Scientific Conference Highlights Breakthroughs in Neuromuscular Research, Innovative Therapies, and Patient Care

Orlando, Florida, March 12, 2026 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) concluded its 2026 MDA Clinical & Scientific Conference yesterday, convening over 2,400 attendees...
February 18, 2026 09:00 ET | Source: Muscular Dystrophy Association

Nationwide MDA Shamrocks Campaign Advances Independence for People Living with Rare Neuromuscular Conditions

New York, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) announced its nationwide MDA Shamrocks campaign, uniting with retail partners across the country to make a...
February 17, 2026 09:00 ET | Source: Muscular Dystrophy Association

Muscular Dystrophy Association Announces Łukasz Sznajder, PhD, MSc, to Receive Inaugural MDA Research Momentum Award

New York, Feb. 17, 2026 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced Łukasz Sznajder, PhD, MSc, Assistant Professor, Department of Chemistry and Biochemistry,...
February 17, 2026 07:00 ET | Source: Entrada Therapeutics, Inc.

Independent Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 12 mg/kg in Entrada Therapeutics’ ELEVATE-44-201 Study

Independent Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 12 mg/kg in Entrada Therapeutics’ ELEVATE-44-201 Study
February 16, 2026 16:02 ET | Source: Matterhorn Fit

Matterhorn Fit Debuts in Fort Lauderdale with Olympian and Florida Panthers alum Steven Kampfer at the Helm

Matterhorn Fit opens in Fort Lauderdale! The elite Matterhorn Method uses neuro-rehab to fix pain and boost performance. Visit 837 NE 2nd Ave today.
February 12, 2026 07:00 ET | Source: NMD Pharma

NMD Pharma results from Phase 2a study of ignaseclant in Charcot-Marie-Tooth disease Types 1 and 2 selected for late-breaking oral presentation at the Muscular Dystrophy Association (MDA) Clinical & Scientific Conference

Aarhus, Denmark, 12 February 2026 – NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore skeletal muscle health, today announced that top-line data...
February 03, 2026 15:03 ET | Source: Muscular Dystrophy Association

Bipartisan Congressional Action Advances Critical Programs for Rare Neuromuscular Disease Research and Care

Washington, D.C., Feb. 03, 2026 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today applauded the bipartisan passage of the annual federal funding bill that sustains critical...
January 26, 2026 09:00 ET | Source: Muscular Dystrophy Association

Muscular Dystrophy Association Marks Rare Disease Day by Spotlighting Community Stories Driving Progress in Research, Care, and Advocacy

New York, Jan. 26, 2026 (GLOBE NEWSWIRE) -- In recognition of Rare Disease Day on February 28, the Muscular Dystrophy Association (MDA) is sharing powerful community stories throughout the month...